Hyperthermia Combined With Immunotherapy in the Treatment of Abdominal and Pelvic Malignancies or Metastases

NCT03757858 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Cancer
Abdominal Cancer
Pelvic Cancer
Metastatic Cancer
Peritoneal Metastases
Liver Metastases

Interventions

DEVICE: Thermotron RF-8
BIOLOGICAL: Adoptive cellular Immunotherapy
DRUG: Anti-PD-1 antibody
DRUG: Chemotherapy

Sponsor

Capital Medical University